The Grigorios Siokas Phenomenon
Siokas doesn't just buy - he uses "Debt Exchange Agreements". Instead of the company repaying him with cash (which it doesn't have), he accepts shares at the current market price.
January 2026: He acquired ~1,000,000 new shares through a series of transactions at prices between $0.44 and $0.52.
Ownership: After the latest purchases, he owns over 8.1 million shares, which is nearly 28% of the entire company.
Why is he doing it? Siokas believes the market is ignoring their record year. Their Greek subsidiary (Cosmofarm) is growing by 20%, and new AI distribution robots are expected to bring in $40 million in additional revenue in 2026.
⚠️ The Big Risk: Nasdaq and the 1st Dollar
COSM has received a warning from Nasdaq because the price is below $1.00. They have 180 days (until June 2026) to raise the price above $1.00. If Siokas' purchases do not raise the price organically, expect a Reverse Stock Split, which is often negative for small investors in the short term.
Siokas doesn't just buy - he uses "Debt Exchange Agreements". Instead of the company repaying him with cash (which it doesn't have), he accepts shares at the current market price.
January 2026: He acquired ~1,000,000 new shares through a series of transactions at prices between $0.44 and $0.52.
Ownership: After the latest purchases, he owns over 8.1 million shares, which is nearly 28% of the entire company.
Why is he doing it? Siokas believes the market is ignoring their record year. Their Greek subsidiary (Cosmofarm) is growing by 20%, and new AI distribution robots are expected to bring in $40 million in additional revenue in 2026.
⚠️ The Big Risk: Nasdaq and the 1st Dollar
COSM has received a warning from Nasdaq because the price is below $1.00. They have 180 days (until June 2026) to raise the price above $1.00. If Siokas' purchases do not raise the price organically, expect a Reverse Stock Split, which is often negative for small investors in the short term.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.